Why the study?
Coronary artery anatomy and myocardium are typically assessed separately, but CTCA-derived coronary lumen volume to myocardial mass ratio has emerged as an integrated in vivo measure of supply and demand.
CTCA-derived coronary lumen volume to myocardial mass ratio (V/M) is an emerging integrated measure of myocardial blood supply and demand that may enhance understanding of cardiovascular disease pathophysiology.
Answers are grounded in this paper and cite their sources.
May enable combined coronary-myocardial evaluation on CCTA; leaves open validation for risk stratification or therapy guidance.
In the absence of disease impacting the coronary arteries or myocardium, there exists a linear relationship between vessel volume and myocardial mass to ensure balanced distribution of blood supply. This balance may be disturbed in diseases of either the coronary artery tree, the myocardium, or both. However, in contemporary evaluation the coronary artery anatomy and myocardium are assessed separately. Recently the coronary lumen volume to myocardial mass ratio (V/M), measured noninvasively using coronary computed tomography angiography (CTCA), has emerged as an integrated measure of myocardial blood supply and demand in vivo. This has the potential to yield new insights into diseases where this balance is altered, thus impacting clinical diagnoses and management. In this review, we outline the scientific methodology underpinning CTCA-derived measurement of V/M. We describe recent studies describing alterations in V/M across a range of cardiovascular conditions, including coronary artery disease, cardiomyopathies and coronary microvascular dysfunction. Lastly, we highlight areas of unmet research need and future directions, where V/M may further enhance our understanding of the pathophysiology of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Ihdayhid et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: